Celgene
NASDAQ: CELG
$108.24
+$0.00 (+0.0%)
Closing Price on November 22, 2019
CELG Articles
The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected biotech stocks.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting their quarterly results this week.
Published:
Last Updated:
The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline potential at current levels.
Published:
Last Updated:
These four top companies are on sale and are very well positioned in their respective sectors. They all look like outstanding buys for the second half of 2016.
Published:
Last Updated:
Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently be the case in the largest stocks in the biotech sector within health care if...
Published:
Last Updated:
The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. After all, a cure or...
Published:
Last Updated:
What a wild and crazy week for investors. The stock market volatility index jumped up and down as the Brexit decision was finally answered. With the quarter coming to an end, some big insiders...
Published:
Last Updated:
Now is the time to look for good growth stocks as the second half of the year could have solid upside after a flat first half.
Published:
Last Updated:
The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
A new JPMorgan research report highlights some large cap secular growth stocks that have shown strong and consistent revenue growth over the past 10 years, even during the recession.
Published:
Last Updated:
The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these selected biotech stocks.
Published:
Last Updated:
With earnings having just been released for some of the top biotech companies, we saw a flurry of analyst calls by the week's end.
Published:
Last Updated:
The April 15 short interest data have been compared with the previous report, and short interest decreased across the board in these selected biotech stocks.
Published:
Last Updated: